• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培养的胶质母细胞瘤细胞中的纤溶酶原激活酶。用单克隆抗体进行的免疫荧光研究。

Plasminogen activating enzyme in cultured glioblastoma cells. An immunofluorescence study with monoclonal antibody.

作者信息

Danø K, Dabelsteen E, Nielsen L S, Kaltoft K, Wilson E L, Zeuthen J

出版信息

J Histochem Cytochem. 1982 Nov;30(11):1165-70. doi: 10.1177/30.11.6183313.

DOI:10.1177/30.11.6183313
PMID:6183313
Abstract

A monoclonal antibody against a 52,000 dalton human plasminogen activating enzyme (HPA52) was used for immunofluorescence staining of cultured glioblastoma cells. The fluorescence was located in the cytoplasm of the cells. A pronounced variation in the staining intensity was observed between the individual cells. The specificity of the fluorescent stain was supported by the findings that 1) no staining was obtained with a monoclonal antibody of the same subclass, but with irrelevant specificity (anti-2,4,6-trinitrophenyl); 2) adsorption with HPA52 purified to homogeneity removed the ability of anti-HPA52 to mediate staining; 3) the glioblastoma cells contained HPA52, as measured by enzymatic assay, while melanoma cells that were not stained did not contain HPA52 activity; 4) dexamethasone reduced both the enzymatically determined HPA52 content and the immunofluorescence in parallel, while progesterone affected none of these parameters; 5) we have previously found that culture fluid conditioned by the glioblastoma cells apart from HPA52 does not contain detectable amounts of any protein that binds to anti-HPA52. Several advantages of immunohistochemical detection of plasminogen activators compared with enzyme histochemical methods are discussed, among these that the immunohistochemical method distinguishes between plasminogen activators of different types.

摘要

一种针对52,000道尔顿人纤溶酶原激活酶(HPA52)的单克隆抗体用于培养的胶质母细胞瘤细胞的免疫荧光染色。荧光位于细胞的细胞质中。在各个细胞之间观察到染色强度有明显差异。荧光染色的特异性得到以下发现的支持:1)用相同亚类但具有无关特异性的单克隆抗体(抗2,4,6-三硝基苯基)未获得染色;2)用纯化至同质的HPA52吸附消除了抗HPA52介导染色的能力;3)通过酶测定法测量,胶质母细胞瘤细胞含有HPA52,而未染色的黑色素瘤细胞不含有HPA52活性;4)地塞米松同时降低了酶测定的HPA52含量和免疫荧光,而孕酮对这些参数均无影响;5)我们之前发现,除HPA52外,由胶质母细胞瘤细胞条件培养液中未检测到任何与抗HPA52结合的蛋白质。讨论了与酶组织化学方法相比,纤溶酶原激活剂免疫组织化学检测的几个优点,其中包括免疫组织化学方法可区分不同类型的纤溶酶原激活剂。

相似文献

1
Plasminogen activating enzyme in cultured glioblastoma cells. An immunofluorescence study with monoclonal antibody.培养的胶质母细胞瘤细胞中的纤溶酶原激活酶。用单克隆抗体进行的免疫荧光研究。
J Histochem Cytochem. 1982 Nov;30(11):1165-70. doi: 10.1177/30.11.6183313.
2
Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.特异性抑制一种人类52,000道尔顿纤溶酶原激活酶的单克隆抗体。
Proc Natl Acad Sci U S A. 1982 Jun;79(12):3720-3. doi: 10.1073/pnas.79.12.3720.
3
Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.针对黑色素瘤细胞来源的66,000分子量人纤溶酶原激活物的单克隆抗体。特异性酶抑制及一步亲和纯化。
EMBO J. 1983;2(1):115-9. doi: 10.1002/j.1460-2075.1983.tb01391.x.
4
Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.使用单克隆抗体和多克隆抗体组合的人尿激酶型纤溶酶原激活剂及其酶原的酶联免疫吸附测定。
J Immunoassay. 1986;7(3):209-28. doi: 10.1080/01971528608060467.
5
Monoclonal antibodies detecting plasminogen activators on the membrane of leukemic lymphoid cells of T-cell origin.
Cancer Detect Prev Suppl. 1987;1:269-77.
6
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.尿激酶型纤溶酶原激活剂及其1型抑制剂在培养的人成纤维细胞和肉瘤细胞下的不同定位。
J Cell Biol. 1987 Apr;104(4):1085-96. doi: 10.1083/jcb.104.4.1085.
7
Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.两种抗人组织型纤溶酶原激活剂单克隆抗体的特性鉴定
Thromb Haemost. 1985 Apr 22;53(2):170-5.
8
Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.在α2-巨球蛋白分泌存在的情况下,组织型纤溶酶原激活物(t-PA)对人黑色素瘤细胞表面纤溶酶原的激活作用。
Cell Regul. 1990 Nov;1(12):895-905. doi: 10.1091/mbc.1.12.895.
9
Immunocytochemical localization of plasminogen activator on porcine kidney cell strain: LLC-PK1 (LP100).纤溶酶原激活剂在猪肾细胞株LLC-PK1(LP100)上的免疫细胞化学定位
J Histochem Cytochem. 1979 Jun;27(6):1035-40. doi: 10.1177/27.6.88472.
10
Plasminogen activators in human malignant melanoma.人类恶性黑色素瘤中的纤溶酶原激活剂
J Natl Cancer Inst. 1984 Jun;72(6):1213-22.

引用本文的文献

1
Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.针对黑色素瘤细胞来源的66,000分子量人纤溶酶原激活物的单克隆抗体。特异性酶抑制及一步亲和纯化。
EMBO J. 1983;2(1):115-9. doi: 10.1002/j.1460-2075.1983.tb01391.x.
2
Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.顺铂耐药的胶质母细胞瘤细胞可能具有更高浓度的尿激酶型纤溶酶原激活剂和1型纤溶酶原激活剂抑制剂。
J Neurooncol. 1999 Apr;42(2):95-102. doi: 10.1023/a:1006125629887.
3
Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors.
人类脑肿瘤中纤溶酶原激活物抑制剂-1(PAI-1)水平升高。
J Neurooncol. 1993 Sep;17(3):215-21. doi: 10.1007/BF01049977.
4
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.使用体外基质胶模型研究纤溶酶原激活剂和92-kDa IV型胶原酶在胶质母细胞瘤侵袭中的作用。
J Neurooncol. 1994;18(2):129-38. doi: 10.1007/BF01050419.
5
Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.恶性星形细胞瘤中尿激酶及尿激酶受体基因的上调
Am J Pathol. 1995 May;146(5):1150-60.
6
Plasminogen activator and hemorrhage in brain tumors.
J Neurooncol. 1994;22(2):183-7. doi: 10.1007/BF01052893.
7
Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression.丝氨酸蛋白酶及其抑制剂在人脑肿瘤进展中的活性、定位和作用
J Neurooncol. 1994;22(2):139-51. doi: 10.1007/BF01052889.
8
Prognostic role of urokinase-type plasminogen activator in human gliomas.尿激酶型纤溶酶原激活剂在人类胶质瘤中的预后作用。
Am J Pathol. 1995 Jul;147(1):114-23.
9
Tumor invasion, proteolysis, and angiogenesis.肿瘤侵袭、蛋白水解作用与血管生成。
J Neurooncol. 1994;18(2):89-103. doi: 10.1007/BF01050415.
10
Invasiveness of primary brain tumors.原发性脑肿瘤的侵袭性。
Cancer Metastasis Rev. 1984;3(3):223-36. doi: 10.1007/BF00048386.